SKI Market

Indian Indices

Sensex

85,041.45 -367.25
( -0.43%)

Global Indices

Nasdaq

48,728.27 -23.90
(-0.05%)

Dow Jones

6,949.98 -3.07
(-0.04%)

Hang Seng

50,641.54 233.75
(0.46%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.83 0.26
(0.29%)

EUR-INR

105.77 0.25
(0.24%)

GBP-INR

121.29 0.43
(0.36%)

JPY-INR

0.58 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Mercury Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

538964

INE947G01011

464.6533333

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

98.26

EPS(TTM)

Face Value()

Div & Yield %

40.95

0.43

Back

Gamco reports consolidated net loss of Rs 8.31 crore in the September 2025 quarter

Oct 23,2025

Net loss of Gamco reported to Rs 8.31 crore in the quarter ended September 2025 as against net profit of Rs 10.55 crore during the previous quarter ended September 2024. Sales rose 285.71% to Rs 86.94 crore in the quarter ended September 2025 as against Rs 22.54 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	86.94	22.54	286
OPM %	-8.09	71.03	-
PBDT	-9.68	14.34	PL
PBT	-9.85	14.31	PL
NP	-8.31	10.55	PL

85,041.45 -367.25 ( -0.43%)

48,728.27 -23.90 (-0.05%)

6,949.98 -3.07 (-0.04%)

50,641.54 233.75 (0.46%)

9,870.68 -18.54 (-0.19%)

89.83 0.26 (0.29%)

105.77 0.25 (0.24%)

121.29 0.43 (0.36%)

0.58 0.00 (0.43%)